Editor | Curator

Advertisment

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi. Recent Wall Street...

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most. The Psychedelic Renaissance is roaring. Over the past...

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering...

Psychedelic Investor TV

To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max, contact Roland Rick Perry at 310-594-8062 or Roland@InstitutionalAnalyst.com...

Protected: 2021 Psychedelic Investor Guide – October

OPEN GUIDE Updated Monthly.. Did we miss your publicly traded company? Contact Roland Perry 310-594-8062

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment for curb substance abuse addictions.

Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom

Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq Capital Market on September 15, 2021, under the...

Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida

"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet, Chief Medical Officer of Ehave.

Editor | Curator

Advertisment